Molecular Pathology of Lung Cancer

2012
ISBN: 978-1-4614-3196-1
Verlag: Springer

Buch, Englisch, Band 6, 216 Seiten, Book, Format (B × H): 178 mm x 254 mm, Gewicht: 630 g

Reihe: Molecular Pathology Library

As with other books in the Molecular Pathology Library Series, Molecular Pathology of Lung Cancer bridges the gap between the molecular specialist and the clinical practitioner, including the surgical pathologist who now has a key role in decisions regarding molecular targeted therapy for lung cancer. Molecular Pathology of Lung Cancer provides the latest information and current insights into the molecular basis for lung cancer, including precursor and preinvasive lesions, molecular diagnosis, molecular targeted therapy, molecular prognosis, molecular radiology and related fields for lung cancer generally and for the specific cell types. As many fundamental concepts about lung cancer have undergone revision in only the past few years, this book will likely be the first to comprehensively cover the new molecular pathology of lung cancer. It provides a foundation in this field for pathologists, medical oncologists, radiation oncologists, thoracic surgeons, thoracic radiologists and their trainees, physician assistants, and nursing staff.

Zielgruppe

Professional/practitioner

Autoren/Hrsg.

Cagle, Philip T.

Allen, Timothy Craig

Beasley, Mary Beth

Chirieac, Lucian R.

Dacic, Sanja

Borczuk, Alain C.

Kerr, Keith M.

Fachgebiete

• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Chirurgie Herz- & Thoraxchirurgie
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Klinische und Innere Medizin Onkologie, Krebsforschung
• Medizin | Veterinärmedizin Medizin | Public Health | Pharmazie | Zahnmedizin Medizinische Fachgebiete Pathologie, Cytopathologie, Histopathologie

Inhaltsverzeichnis

Section 1. Molecular Pathology of Lung Cancer: General Principles
Ch. 1: Approach to Personalized Care of the Lung Cancer Patient
Philip T. Cagle
Ch. 2: Etiology of Lung Cancer
Philip T. Cagle
Ch. 3: Genetic Susceptibility to Lung Cancer
Timothy Craig Allen
Ch. 4: Lung Cancer Stem Cells
Timothy Craig Allen
Ch. 5: The Classification of Pre-Invasive Lesions
Keith M. Kerr
Ch. 6: Molecular Pathology of Precursor and Pre-Invasive Lesions
Keith M. Kerr
Ch. 7: Revised Classification for Adenocarcinoma
Philip T. Cagle
Keith M. Kerr
Ch. 8: Molecular Basis for the Current Lung Cancer Classification
Alain C. Borczuk
Ch. 9: Molecular Diagnosis of Lung Cancer
Lucian R. Chirieac
Philip T. Cagle
Ch. 10: Molecular Targeted Therapy of Lung Cancer
Sanja Dacic
Ch. 11: Molecular Prognostic Markers of Lung Cancer
Sanja Dacic
Ch. 12: New Techniques for Optical and Molecular Visualization of Lung Cancer
Philip T. Cagle

Section 2. Molecular Pathology of Lung Cancer: Specific Histologic Types
Ch. 13: Adenocarcinoma
Keith M. Kerr
Ch. 14: Squamous Cell Carcinoma
Timothy Craig Allen
Ch. 15: Molecular Pathology of Large Cell Carcinoma
Alain C. Borczuk
Ch. 16: Molecular Pathology of Small Cell Carcinomas
Mary Beth Beasley
Ch. 17: Molecular Biopsy of Neuroendocrine Carcinomas Other Than Small Cell
Carcinoma
Mary Beth Beasley
Ch. 18: Molecular Pathology of Uncommon Carcinomas
Alain C. Borczuk
Ch. 19: Biology of Lung Cancer Metastases
Lucian R. Chirieac

Über Autor(innen)

Philip T. Cagle, MD
The Methodist Hospital, Houston, TX, USA
Timothy Craig Allen, MD, JD
The University of Texas Health Science Center at Tyler, TX, USA
Mary Beth Beasley, MD
Mount Sinai Medical Center, New York, NY, USA
Lucian R. Chirieac, MD
Brigham and Women’s Hospital, Boston, MA, USA
Sanja Dacic, MD, PhD
University of Pittsburgh Medical Center, PA, USA
Alain C. Borczuk, MD
Columbia University Medical Center, New York, NY, USA
Keith M. Kerr, MD, FRCPath
Aberdeen University Medical School, Scotland, UK